5/8
12:37 am
arct
Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2026 Earnings Call Transcript [Seeking Alpha]
High
Report
Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2026 Earnings Call Transcript [Seeking Alpha]
5/7
04:01 pm
arct
Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress
Medium
Report
Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress
4/27
04:01 pm
arct
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026
Medium
Report
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026
4/22
06:00 pm
arct
Arcturus Therapeutics (ARCT) was upgraded by
Weiss Ratings from "sell (e+)" to "sell (d-)".
Low
Report
Arcturus Therapeutics (ARCT) was upgraded by
Weiss Ratings from "sell (e+)" to "sell (d-)".
3/23
03:08 pm
arct
Arcturus Therapeutics Refocuses on Rare Disease mRNA Pipeline After COVID Vaccine Success at ROTH Conf [Yahoo! Finance]
Low
Report
Arcturus Therapeutics Refocuses on Rare Disease mRNA Pipeline After COVID Vaccine Success at ROTH Conf [Yahoo! Finance]
3/23
07:34 am
arct
These Are the Only 3 Stocks That Cathie Wood Bought Last Week [Yahoo! Finance]
Medium
Report
These Are the Only 3 Stocks That Cathie Wood Bought Last Week [Yahoo! Finance]
3/20
08:07 am
arct
Arcturus Therapeutics (ARCT) was upgraded by B. Riley Financial, Inc. to "strong-buy".
Low
Report
Arcturus Therapeutics (ARCT) was upgraded by B. Riley Financial, Inc. to "strong-buy".
3/18
08:03 am
arct
Arcturus Therapeutics (ARCT) is now covered by B. Riley Financial, Inc.. They set a "buy" rating and a $22.00 price target on the stock.
Low
Report
Arcturus Therapeutics (ARCT) is now covered by B. Riley Financial, Inc.. They set a "buy" rating and a $22.00 price target on the stock.
3/12
02:17 am
arct
Arcturus Therapeutics Teases 12-Week Phase 2 CF Study After Well-Tolerated Inhaled mRNA Dosing [Yahoo! Finance]
Medium
Report
Arcturus Therapeutics Teases 12-Week Phase 2 CF Study After Well-Tolerated Inhaled mRNA Dosing [Yahoo! Finance]
3/6
04:08 pm
arct
Arcturus Therapeutics: Downgrading To "Hold" As CF Program Shifts Population Focus [Seeking Alpha]
Medium
Report
Arcturus Therapeutics: Downgrading To "Hold" As CF Program Shifts Population Focus [Seeking Alpha]
3/5
03:24 pm
arct
Arcturus Therapeutics (ARCT) had its price target lowered by Citigroup Inc. from $66.00 to $21.00. They now have a "buy" rating on the stock.
Neutral
Report
Arcturus Therapeutics (ARCT) had its price target lowered by Citigroup Inc. from $66.00 to $21.00. They now have a "buy" rating on the stock.
3/5
09:00 am
arct
Arcturus Therapeutics to Attend Upcoming Investor Conference
Medium
Report
Arcturus Therapeutics to Attend Upcoming Investor Conference
3/4
01:39 pm
arct
Arcturus Therapeutics (ARCT) had its price target raised by Citigroup Inc. from $7.00 to $8.00. They now have a "neutral" rating on the stock.
Low
Report
Arcturus Therapeutics (ARCT) had its price target raised by Citigroup Inc. from $7.00 to $8.00. They now have a "neutral" rating on the stock.
3/4
08:50 am
arct
Arcturus Therapeutics (ARCT) had its price target lowered by Piper Sandler from $72.00 to $25.00. They now have an "overweight" rating on the stock.
Low
Report
Arcturus Therapeutics (ARCT) had its price target lowered by Piper Sandler from $72.00 to $25.00. They now have an "overweight" rating on the stock.
3/4
12:15 am
arct
Arcturus Therapeutics Holdings Inc (ARCT) Q4 2025 Earnings Call Highlights: Navigating Revenue ... [Yahoo! Finance]
Low
Report
Arcturus Therapeutics Holdings Inc (ARCT) Q4 2025 Earnings Call Highlights: Navigating Revenue ... [Yahoo! Finance]
3/3
07:03 pm
arct
Arcturus (ARCT) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Arcturus (ARCT) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
3/3
06:25 pm
arct
Arcturus Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Arcturus Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
3/3
04:27 pm
arct
Arcturus Therapeutics: Q4 Earnings Snapshot [Yahoo! Finance]
Neutral
Report
Arcturus Therapeutics: Q4 Earnings Snapshot [Yahoo! Finance]
3/3
04:11 pm
arct
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress [Yahoo! Finance]
Medium
Report
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress [Yahoo! Finance]
3/3
04:01 pm
arct
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress
Medium
Report
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress